Company: TBPH
Filing Date: 2025-11-10
Form Type: 8-K
Source: 0001104659-25-109146
Chunk: 0

Company: Theravance Biopharma, Inc.
Filing Date: 2025-11-10
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item
2.02. Results of Operations and Financial Condition.

On
November 10, 2025, Theravance Biopharma, Inc. (the “ Company”) issued a press release and is holding a conference call regarding
its financial results for the quarter ended September 30, 2025, and a business update. A copy of the press release is furnished as Exhibit
99.1 to this Current Report and a copy of materials that will accompany the call is furnished as Exhibit 99.2 to this Current Report.

The
information in Item 2.02 and in Item 9.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, is being furnished and
shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Securities
Exchange Act of 1934”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as expressly set forth by specific
reference in such a filing.